Abiopharma

🔍 CITRIN JEFFREY B (Director)

Company: TANGER INC. (SKT)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 617 shares of Common Stock at $38.49 per share (Direct)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 152,134.55 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents deferred share units issued pursuant to the Director Deferred Share Program of Tanger Inc. and Tanger Properties Limited Partnership. Each deferred share unit is equivalent to one common share. The deferred share units become payable in common shares upon termination of his service as a director.
• F2: Since the Reporting Person's last Form 4, 105.09 deferred share units were acquired through a dividend reinvestment program.